Dibromido{N′-[1-(pyridin-2-yl)ethyl­idene]picolinohydrazide-κ2 N′,O}cadmium

The title compound, [CdBr2(C13H12N4O)], was obtained from the reaction of Cd(NO3)2·4H2O with meth­yl(pyridin-2-yl)methanone picolinoylhydrazone and sodium bromide. The Cd2+ cation is ligated by one O atom and two N atoms of the tridentate ligand and two bromide anions, forming a Br2CdN2O polyhedron with a distorted trigonal–bipyramidal coordination geometry. In the crystal, non-classical C—H⋯Br hydrogen bonds are observed. In addition, π–π stacking inter­actions [centroid–centroid distance = 3.7455 (19) Å] contribute to the stabilization of the crystal structure

The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019

Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe

Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017 : A systematic analysis for the global burden of disease study

Importance: Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting, and budgeting have been identified as major obstacles in achieving these goals. All of these have in common that they require information on the local cancer epidemiology. The Global Burden of Disease (GBD) study is uniquely poised to provide these crucial data. Objective: To describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning. Evidence Review: We used the GBD study estimation methods to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-Adjusted life-years (DALYs). Results are presented at the national level as well as by Socio-demographic Index (SDI), a composite indicator of income, educational attainment, and total fertility rate. We also analyzed the influence of the epidemiological vs the demographic transition on cancer incidence. Findings: In 2017, there were 24.5 million incident cancer cases worldwide (16.8 million without nonmelanoma skin cancer [NMSC]) and 9.6 million cancer deaths. The majority of cancer DALYs came from years of life lost (97%), and only 3% came from years lived with disability. The odds of developing cancer were the lowest in the low SDI quintile (1 in 7) and the highest in the high SDI quintile (1 in 2) for both sexes. In 2017, the most common incident cancers in men were NMSC (4.3 million incident cases); tracheal, bronchus, and lung (TBL) cancer (1.5 million incident cases); and prostate cancer (1.3 million incident cases). The most common causes of cancer deaths and DALYs for men were TBL cancer (1.3 million deaths and 28.4 million DALYs), liver cancer (572000 deaths and 15.2 million DALYs), and stomach cancer (542000 deaths and 12.2 million DALYs). For women in 2017, the most common incident cancers were NMSC (3.3 million incident cases), breast cancer (1.9 million incident cases), and colorectal cancer (819000 incident cases). The leading causes of cancer deaths and DALYs for women were breast cancer (601000 deaths and 17.4 million DALYs), TBL cancer (596000 deaths and 12.6 million DALYs), and colorectal cancer (414000 deaths and 8.3 million DALYs). Conclusions and Relevance: The national epidemiological profiles of cancer burden in the GBD study show large heterogeneities, which are a reflection of different exposures to risk factors, economic settings, lifestyles, and access to care and screening. The GBD study can be used by policy makers and other stakeholders to develop and improve national and local cancer control in order to achieve the global targets and improve equity in cancer care. © 2019 American Medical Association. All rights reserved.Peer reviewe

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and developm nt investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Anion-directed assemblies of Cu(II) mono, di, and poly-nuclear coordination compounds with a 32-membered azacrown ligand: Synthesis, characterisation and crystal structures

A novel 32-membered azacrown ligand L was synthesized from the [2 + 2] condensation between 2-[3-(2-formylphenoxy)-2-hydroxy propoxy]benzaldehyde and 1,2-diaminopropane by following in situ reduction. Three metal-organic coordination compounds $[CuL(NCS)]NO_3·CH_3OH (1), [Cu_2L(CH_3COO)_4].0.5_H2O (2)$, and $[CuL(μ-Cl)(NO_3)]_n.2nCH_3CN (3)$, were prepared from reaction of L with copper(II) salts containing different anions. Depending on the reaction controlling factor, i.e. $NCS^−, CH_3COO^−$, , and $Cl^−$anions, mono, di and polynuclear metal-organic coordination compounds were constructed. Complexes were characterized by spectroscopic methods and single crystal X-ray diffraction. Crystal structures indicate that L in presence of $NCS^−$ and $Cu(NO_3)_2·3H_2O$ forms mononuclear complex 1. Dinuclear complex 2 was formed by the reaction of L in presence of $Cu(CH_3COO)_2·2H_2O$. Reaction of $Cu(NO_3)_2·3H_2O$ and $CuCl_2·3H_2O$ with L give rise complex 3 which is a 1-dimensional coordination polymer. The coordination polymer constructed from distorted octahedron shaped copper nucleus that are exomacrocylic in which two Cl atoms serve as bridge. Potentially decadentate ligand, L, with four N- and six O-donor sites in presence of Cu(II) salts reacts only with its N-donors. Complexes 1 and 3, both, are crystalized in a centrosymmetric space group $P2_{1/c}$ and dinuclear complex 2 is crystalized in a polar space group $P2_1$

Synthesis, characterization, spectrophotometric and electrochemistry studies, and DNA cleavage of copper(II) complexes of a new azacrown bis-macrocycle and its mono-cyclic analogue

A new azacrown bis-macrocycle (5) and its mono–cyclic analogue (7) were synthesized and characterized by FT-IR, 1H NMR, 13C NMR, DEPT 13C NMR, MS, and elemental analysis. The reaction with copper(II) nitrate yielded the corresponding complexes, formulated as Cu(5)(NO3)2·3H2O (8), and Cu(7)(NO3)2·2.5H2O (9). Also the stoichiometries of the complexes were determined in alcoholic solution and the results show that for both complexes the ratio of ligand to metal was 1:1 in methanol. The redox behavior of both complexes has been studied by cyclic voltammetry in DMF. Cyclic voltamogram of 8 shows quasi-reversible CuII/CuI redox couple whereas 9 shows a reversible CuII/CuI redox couple. Mono- and bis-macrocycle copper(II) complexes (8 and 9 respectively) cleaved plasmid pGS2 DNA by using an oxidative mechanism with 3- mercaptopropionic acid (MPA) as the reductant under aerobic conditions. The bis-macrocycle copper(II) complex 8 showed higher cleavage efficiency than their mono-macrocycle analogue 9 at the same Cu2+ concentration

Copper(II) and zinc(II) complexes of mono- and tri-linked azacrown macrocycles: Synthesis, characterization, X-ray structure, phosphodiester hydrolysis and DNA cleavage

A new tri-linked azacrown macrocycle (L2) was synthesized from mono macrocycle analogue (L1) by Williamson etherification and characterized by FT-IR, H-1 NMR, C-13 NMR, DEPT C-13 NMR, MS, and elemental analysis. The reaction of copper(II) and zinc(II) salts yielded corresponding complexes and formulated as CuL1Cl(2) (1), CuL1(NO3)(2).3H(2)O (2), Cu(2)L2(NO3)(4.)4H(2)O (3), ZnL1(OAc)(2) (4) and Zn(3)L2(OAc)(6).3H(2)O (5). Mono and trinuclear zinc(II) complexes 4 and 5, respectively, have been tested as catalysts for hydrolysis of 2-hydroxylpropyl-4-nitrophenyl phosphate (HNPP). At pH 8.5 the mononuclear complex 4 was found to be inactive. In contrast, trinuclear complex 5 was hydrolyzing phosphodiester and the reaction was up to 35-fold faster than the unpromoted reaction. Mono and dinuclear copper(II) complexes 2 and 3 cleave plasmid pG2 DNA by using an oxidative mechanism under aerobic conditions. Dinuclear copper(II) complex 3 showed a much higher cleavage efficiency than its mononuclear analogue 2 at the same Cu2+ concentration. The X-ray structure of 1 is reported. In this complex, the Cu(II) is bound by three amine nitrogens from the macrocyclic ligand L1 and two chloride anions as distorted trigonal bipyramidal geometry

Syntheses, studies and crystal structures of coordination polymers and dinuclear complexes of mercury(II) halides and thiocyanate with a symmetrical Schiff base ligand

A series of mercury(II) compounds, [Hg-2(mu-L)(SCN)(4)](n) (1), [Hg-2(mu-L)(mu-Cl)(2)Cl-2](n) (2), [Hg-2(mu-L)Br-4]center dot[Hg-2(mu-L)(mu-Br)(2)Br-2](n) (3) and [Hg-2(mu-L)I-4] (4) {L = N,N'-(bis-(pyridin-2-yl)benzylidene)-1,2-ethanediamine} have been prepared and characterized by using microanalytical, spectroscopic, thermal and X-ray crystallographic results. In solid states 1 and 2 have 2D and 1D coordination polymer structure, respectively. Solid state 3 consists of both 1D coordination polymers and dinuclear units. Solid state 4 is only composed of dinuclear units. In the polymeric structures, each mercury(II) center is five coordinated with trigonal bipyramidal geometry in 1D and square pyramidal environment in 2D coordination polymers. Coordination geometry around Hg centers in dinuclear units is tetrahedral. HOMO and LUMO of the title compounds and also the energy gap among them have been studied by using the density functional theory (DFT/B3LYP) method with the LANL2DZ pseudo-potential.University of Tabriz Research Counci